Feline hyperthyroidism is the most common endocrine disease in middle-aged to senior cats and requires careful management to optimize welfare alongside thyroid control.
Hyperthyroidism causes significant metabolic burden — despite increased appetite, cats lose weight and muscle condition, and untreated cardiac and renal complications cause further welfare impairment. Treatment choice should consider individual cat temperament, owner capabilities, and cost. Daily oral medication is effective but stressful for many cats; transdermal gel reduces administration stress. Post-treatment monitoring for renal disease allows early intervention. Quality of life is measurably improved with effective thyroid control in most cats.